A MultiCtr,OL,dosageranging study in early,untreated or stably treated subjects with Parkinson's PD to determine the safety,tolerability and PK of inj ofSER-214administered subcu once a week for two weeks after 0-2 weeks of dose titration.

Administered By

Awarded By

Contributors

Start/End

  • January 1, 2016 - October 31, 2017